Yankees' Late-Season Shuffle: Volpe's Positional Experiment and the Stanton-Grisham Return Window

Aaron Boone confirmed Wednesday that Anthony Volpe could see time at third base during the final week of the regular season, a positional shift born from necessity rather than long-term planning. Volpe spent five weeks experimenting with the position in Triple-A between early August and early September, and the shortstop-turned-utility option now presents the Yankees with a defensive flexibility play as they finalize their postseason lineup. The move addresses a crowded infield where Jazz Chisholm Jr. returns at second, rookie George Lombard Jr. remains entrenched at short, and Ryan McMahon continues to anchor third base.

The more significant narrative, however, centers on two damaged bats racing against the calendar. Giancarlo Stanton—absent since April due to a left calf strain that sidelined him for five months—is heading to Double-A Somerset for live at-bats as part of the team's rehab contingent. Trent Grisham, who landed on the injured list on September 5 with a right hamstring strain, has progressed far enough in his running program that Boone believes a postseason contribution is possible. Both players are operating on a compressed timeline: with the regular season effectively over for playoff-bound rosters and the Wild Card series looming within days, neither Stanton nor Grisham can afford extended minor-league acclimation. The at-bats at Somerset represent a final checkpoint before roster decisions lock in.

The backdrop is unavoidable: Aaron Judge (right calf strain) remains a question mark through the Wild Card round at minimum, meaning the Yankees are building their October lineup without their captain and home-run anchor. Stanton's return from a five-month absence raises a structural concern—hitters of his physical profile typically require 15–20 live competitive at-bats to recalibrate bat speed and timing recognition—yet the postseason window compresses that window to single digits. Grisham faces a similar compression: a hamstring strain that landed him on September 5 has allowed him to progress to full baseball activity in three weeks, but hamstring re-injury risk peaks when players transition from controlled environment (training) to game stress and explosive load.

From a betting lens, the Yankees' team total and over-under lines carry hidden volatility. If Stanton and Grisham become functional contributors for even one or two playoff games, Yankees run production spikes meaningfully—Stanton's career .510 slugging percentage would be a plus-power addition to any October lineup. But the probability they appear in the Wild Card (less than a week away) is near zero; a realistic scenario is their arrival for Division Series games (10+ days out) at best. Market-makers have already adjusted team totals for Judge's absence and the Grisham-Stanton uncertainty, embedding a discount for injury-plagued roster depth. The edge for contrarian bettors emerges if either bat does return for a postseason series: the line would already be priced for their absence, creating a one-way leverage scenario on totals in games where they're suddenly active.

Volpe's positional versatility, meanwhile, carries marginal prop implications for the regular season but matters tactically for October. A utility shortstop who can play both middle-infield spots and third base increases roster elasticity without forcing the Yankees to sacrifice an offensive player for defensive flexibility. Late-September games against already-eliminated opponents are the laboratory; Boone's willingness to test Volpe at third now suggests confidence in the position transition if injuries force a playoff pivot.